Anti-BCMA Antibody

BPS Bioscience

Anti-BCMA Antibody

7

Research Use Only

Monoclonal

≥90%

TNFRSF17

TNF receptor superfamily member 17

B cell maturation antigen; B-cell maturation factor; B-cell maturation protein; BCM; BCMA; CD269; TNFRSF13A; tumor necrosis factor receptor superfamily member 17

IgG1

This anti-BCMA antibody is a purified, biotinylated, recombinant human monoclonal antibody which recognizes the human BCMA protein. BCMA is also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17) and is expressed on the surface of plasma cells. BCMA is important for plasma cell differentiation and B cell proliferation. BCMA is a validated therapeutic target in multiple myeloma. The first anti-BCMA CAR-T cell therapy (idecabt agene vicleucel) was approved by the FDA in 2021.

-80°C

12352203